当归提取物及复方制剂治疗克罗恩病肛瘘术后的作用机制的研究进展  

Research Progress on the Mechanism of Effect of Angelica Extract and Compound Preparation in the Treatment of Postoperative Anal Fistula in Crohn's Disease

在线阅读下载全文

作  者:侯亚如 张博 李勇 董娟 康雪莲 张悦 李心语 HOU Ya-ru;ZHANG Bo;LI Yong;DONG Juan;KANG Xue-lian;ZHANG Yue;LI Xin-yu(Gansu University of Chinese Medicine Clinical School of Chinese medicine,Lanzhou,Gansu,730000,China;Proctology Department 2,Qingyang Hospital of Traditional Chinese Medicine,Qingyang,Gnasu,745000,China)

机构地区:[1]甘肃中医药大学中医临床学院,甘肃兰州730000 [2]甘肃省庆阳市中医医院肛肠二科,甘肃庆阳745000

出  处:《现代生物医学进展》2025年第4期788-800,共13页Progress in Modern Biomedicine

基  金:甘肃省中医药管理局项目(GZKP-2023-62)。

摘  要:克罗恩病(Crohn's disease,CD)是一种以肠道炎性病变为主要表现的全身性疾病,肛瘘是其最常见的并发症之一,被称之为克罗恩病肛瘘(Crohn's disease anal fistula,pfCD).pfCD的典型临床表现为腹痛、慢性腹泻、大便出血和肛周疼痛、溃疡等,其发病机制尚不完全清楚.目前,西医治疗pfCD除了常规手术治疗外,以口服抗菌药物、免疫抑制剂、生物制剂等为主,但副作用较多.当归是临床上应用较广的传统中药材之一,含多糖、有机酸、挥发油及苯肽类等活性成分.现代药理学研究表明当归具有抗炎、镇痛、免疫调节和神经保护等多种药理作用.本文对当归提取物及其复方制剂治疗pfCD的作用及机制的研究进展进行了综述,以期为pfCD的临床治疗提供更多的参考依据.Crohn's disease(CD)is a systemic disease mainly characterized by intestinal inflammatory lesions,and anal fistula is one of the most common complications,which is called Crohn's disease anal fistula(pfCD).The typical clinical manifestations of pfCD are abdominal pain,chronic diarrhea,bleeding stool,perianal pain and ulcer,etc.The pathogenesis of pfCD is still not fully understood.At present,in addition to conventional surgical treatment of pfCD,Western medicine mainly uses oral antibacterial drugs,immunosuppressants,biological agents,etc.but there are many side effects.Angelica sinensis is one of the most widely used traditional Chinese medicinal materials in clinical practice.It contains polysaccharides,organic acids,volatile oils and phenylpeptides.Modern pharmacological studies show that Angelica sinensis has many pharmacological effects such as anti-inflammatory,analgesic,immunomodulatory and neuroprotective.In this paper,the effects and mechanism of Angelica sinensis extract and its compound preparation on pfCD were reviewed,in order to provide more reference for the clinical treatment of pfCD.

关 键 词:当归 当归有效成分 克罗恩病肛瘘 当归复方 研究进展 

分 类 号:R3[医药卫生—基础医学] R33R587.2

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象